PaperPanda Equity Terminal

RPRX logo RPRX — Royalty Pharma Plc

CUSIP: G7709Q104 · Held by 4 superinvestors · Combined value: $454,216,223

Latest News

Loading financials…

Quarterly Activity Chart Adds vs. Reduces by Quarter
Green bars = share additions · Red bars = share reductions
Superinvestor Holders
# Investor % of Portfolio Value ($) Shares Recent Activity Share Change
1 Ken Griffin 0.0% $207,136,096 5,360,665 ADD +4,781,792
2 Samantha McLemore 5.0% $128,813,194 3,333,675 ADD +215,825
3 Pat Dorsey 7.6% $87,305,882 2,259,469 REDUCE -90,980
4 Torray LLC 4.5% $30,961,051 645,425 REDUCE -98,930
Quarterly Activity History (3 quarters)
Investor Activity Share Change % Change
Torray LLC REDUCE -98,930 -13.3%
Investor Activity Share Change % Change
Ken Griffin ADD +4,781,792 +826.1%
Samantha McLemore ADD +215,825 +6.9%
Torray LLC ADD +41,472 +5.9%
Pat Dorsey REDUCE -90,980 -3.9%
Investor Activity Share Change % Change
Pat Dorsey NEW BUY +2,350,449 New
Samantha McLemore ADD +129,862 +4.3%
Ken Griffin REDUCE -290,015 -33.4%
Andreas Halvorsen SOLD -2,597,460 Exit

Who Owns RPRX? Superinvestor Holdings

Royalty Pharma Plc is held by 4 tracked superinvestors, with a combined position value of $454 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Samantha McLemore (5.0% of portfolio), Pat Dorsey (7.6% of portfolio).

In the most recent quarter, 2 superinvestors added or initiated positions while 2 reduced or exited.